Skip to main content
Log in

Congestive Heart Failure

Epidemiology and Cost of Illness

  • Review Article
  • Epidemiology
  • Published:
Disease Management & Health Outcomes

Summary

Congestive heart failure (CHF), a state of abnormal cardiac function, is a common end-stage of heart disease, greatly shortening survival. In the US, as in many countries, it is an increasingly major burden on families and the healthcare system. Nearly 5 million people have CHF, it is the leading diagnosis in hospitalisations of persons aged 65 years and over, 13% of all deaths in 1993 had CHF mentioned on the death certificate, and healthcare expenditures amounted to $US17.5 billion in 1993.

Prevalence, mortality, hospitalisations and visits to physicians for CHF are increasing. They are expected to continue increasing as the numbers of older persons in the population increase and as survival following coronary heart disease continues to improve. In a community cohort study, median survival following initial CHF was only 1.7 years in men and 3.2 years in women.

The risk of CHF depends on a person’s status with respect to predisposing diseases and risk factors. Hypertension, which is present in 50 million people, carries the largest attributable risk of CHF. Myocardial infarction carries the next highest attributable risk, followed by diabetes. Means for early detection and control of hypertension and myocardial infarction have been proven effective, however, they are not being fully utilised. The goal should be to prevent or limit myocardial damage before CHF ensues. Using ordinary office procedures, high risk candidates for CHF can be detected before overt manifestations present. Treatment of hypertension and left ventricular dysfunction can decrease incidence of CHF, and use of ACE inhibitors or vasodilators can prolong survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. National Heart, Lung, and Blood Institute. Data fact sheet: congestive heart failure in the United States: a new epidemic. Bethesda (MD): NHLBI Information Center, 1996 Sep

    Google Scholar 

  2. Schocken DD, Arrieta MI, Leaverton PE, et al. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992 Aug; 20(2): 301–6

    Article  PubMed  CAS  Google Scholar 

  3. Ho KKL, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993 Oct; 22(4): 6A–13A

    Article  PubMed  CAS  Google Scholar 

  4. Kannel WB, Thom TJ. Incidence, prevalence, and mortality of cardiovascular diseases. In: Schlant RC, Alexander RW, editors. The heart. 8th ed. New York: McGraw Hill, Inc., 1994

    Google Scholar 

  5. Ho KKL, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circ Res 1993 Jul; 88(1): 107–15

    CAS  Google Scholar 

  6. Gillum RF. Epidemiology of heart failure in the United States. Am Heart J 1993; 126: 1042–7

    Article  PubMed  CAS  Google Scholar 

  7. Andrews R, Cowley AJ. Clinical and economic factors in the treatment of congestive heart failure. Pharmacoeconomics 1995; 7(2) 119–27

    Article  PubMed  CAS  Google Scholar 

  8. McMurray J, McDonough T, Morrison CE, et al. Trends for hospitalization for heart failure in Scotland, 1980–1990. Eur Heart J 1993; (14): 1158–62

    Google Scholar 

  9. National Heart, Lung, and Blood Institute. Morbidity and mortality chartbook on cardiovascular, lung, and blood diseases, 1996. National Institutes of Health. Bethesda (MD): NHLBI, 1996

    Google Scholar 

  10. Kilip T. Epidemiology of congestive heart failure. Am J Cardiol 1985 Jul; 56: 2A–6A

    Article  Google Scholar 

  11. National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes in America; 1995. 2nd ed. NIH Publication No. 95-1468

  12. National Center for Health Statistics. Health, United States, 1995. Hyattsville (MD): Public Health Service, 1995. DHHS Publication no. 96–1232

    Google Scholar 

  13. Gillum RF, Foison AR, Blackburn H. The decline in coronary heart disease mortality: old questions and new facts. Am J Med 1984 (76): 1055–65

    Google Scholar 

  14. Graves EJ, Gillum BS. 1994 Summary: national hospital discharge survey: advance data. Hyattsville (MD): National Center for Health Statistics, 1996; (278): 1–12

    Google Scholar 

  15. Ranofsky A. Inpatient utilization of short-stay hospitals by diagnosis: United States, 1971. Hyattsville (MD): National Center for Health Statistics, Department of Health Education and Welfare, 1974. Publication no. (HRA) 75-1767

    Google Scholar 

  16. Glickman L. Inpatient utilization of short-stay hospitals by diagnosis: United States, 1974. National Hospital Discharge Survey. Vital and health statistics. Hyattsville (MD): National Center for Health Statistics, Department of Health and Human Services, 1977 series 13 (30). Publication no. (PHS) 77-1783

    Google Scholar 

  17. Graves EJ. Inpatient utilization of short-stay hospitals by diagnosis: United States, 1984. National Hospital Discharge Survey. Vital and health statistics. Hyattsville (MD): National Center for Health Statistics, Department of Health and Human Services, 1987 series 13 (89). Publication no. (PHS) 87-1750

    Google Scholar 

  18. Haupt B, Hing E, Strahan G. The National Home and Hospice Care Survey; 1992 Summary. Vital and health statistics. Hyattsville (MD): National Center for Health Statistics, 1994: series 13, no. 117

    Google Scholar 

  19. American Heart Association. 1997 heart and stroke: statistical update. Dallas (TX): American Heart Association, 1996

    Google Scholar 

  20. Elixhauser A, Andrews RM, Fox S. Clinical classifications for health policy research: discharge statistics by principal diagnosis and procedure. Agency for Health Care Policy and Research. U.S. Department of Health and Human Resources; 1993. Provider studies research note 17. AHCPR Publication no. 93-0043

  21. Levy D, Larson MG, Ramachandran S, et al. The progression from hypertension to congestive heart failure. JAMA 1996 May; 275(20): 1557–62

    Article  PubMed  CAS  Google Scholar 

  22. Kannel WB. Need and prospects for prevention of cardiac failure. Eur J Clin Pharm 1996; 49 Suppl.: S3–S9

    Google Scholar 

  23. Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994; 72 Suppl.: S3–S9

    Article  PubMed  CAS  Google Scholar 

  24. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991; (121) 3 Pt 1: 951–7

    Google Scholar 

  25. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; (327): 685–91

    Google Scholar 

  26. U.S. Department of Health and Human Services. National Heart, Lung, and Blood Institute report of the Task Force on Research in Heart Failure. Bethesda (MD): NHLBI Information Center, 1994 May

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas J. Thom.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thom, T.J., Kannel, W.B. Congestive Heart Failure. Dis Manage Health Outcomes 1, 75–83 (1997). https://doi.org/10.2165/00115677-199701020-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-199701020-00002

Keywords

Navigation